Infectious Diseases

Infectious Diseases


Drug Watch / Vaccine Watch

FDA Approves Ceftolozane/ Tazobactam (Zerbaxa)

Ceftolozane/tazobactam is a new combination cephalosporin/β-lactamase inhibitor with activity against some multidrug-resistant gram-negative bacteria.

HIV and ID Observations Blog

Quick Question: Should We Still Be Recommending This Year's Flu Vaccine? Free

In HIV and ID Observations, Dr. Paul Sax answers a question for a colleague about whether or not it makes sense to still recommend the flu vaccine.

Guideline Watch

Prevention and Control of Seasonal Influenza

An update to the recommendations for 2013–2014